Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non ‐alcoholic fatty liver disease

Liver International, EarlyView.
Source: Liver International - Category: Gastroenterology Source Type: research